** Weir on the verge of a surprise deletion from the FTSE 100 if the co underperforms Informa by another 80 bps by the close on Tuesday ** Current market cap of £3,621 bln 0.8 pct higher than Informa (£3,595), the stock in 111th place and therefore eligible for promotion if it passes Weir
Read more** Tullow Oil easily top FTSE 100 faller, down 7.3 pct & poised for biggest one-day drop since late Nov ** Worries that an ongoing maritime dispute between Ghana and Cote d'Ivoire could result in suspension of ops see shares accelerate losses after weak open ** Tullow got 85 pct of it
Read moreA massive cash return by Glaxosmithkline gave the wider sector a lift on Wednesday, with defensive healthcare and pharmaceutical stocks also benefiting from a reduction in risk appetite as UK markets pulled back from a five-month high. Sales, profits and earnings slumped during the fourth quarter of
Read more** Drugmaker's shares up 4.4 pct to life-high after Hikma says Takeda Pharmaceutical unsuccessful in appealing U.S. court decision to deny preliminary injunction of the Jordanian company's drug for gout flares. ** Hikma is the top gainer on the FTSE-350 Pharmaceuticals & Biotechnology index
Read moreA US court has given Hikma Pharmaceuticals permission to distribute its colchicine gout treatment, turning down rival Takeda Pharmaceuticals in its appeal for an injunction against the distribution of the drugs. The injunction, which was granted to Takeda on 9 October 2014, has been vacated followin
Read moreOil producers such as Afren and Premier Oil, and energy services firms Wood Group, Hunting and Petrofac, were all falling sharply on Monday as the price of oil continued to sink. Brent crude dropped below $55 a barrel (bbl) for the first time since May 2009. Afren was also continuing to decline afte
Read moreUK stocks were trading firmly in the red by Monday lunchtime despite a positive start, with shares in the oil and mining sectors providing a drag. London's FTSE 100 was down 0.9% at 6,489 by midday, dropping sharply after reaching a high of 6,576.74 early on. This week will be the first full tradin
Read moreHikma Pharmaceuticals shares edged closer to an all-time high on Monday, in the wake of bullish recommendation from two brokers. The stock, which rose 66.8% in 2014, was among Europe's best performing small-cap after JP Morgan lifted its price target on Hikma shares by 18.4% and maintained an 'overw
Read more